Lund University

Lund University

Lund University

Overview
Date Founded

1938

Headquarters

Box 117 Lund, Skane Lan, 221 00, Sweden

Employees (Worldwide)

5,001 - 10K

Industries

Human Resources & Personnel Services

Company Description

The University is ranked as one of the top 100 in the world. They tackle complex problems and global challenges and work to ensure that knowledge and innovations benefit society. They provide education and research in engineering, science, law, social sciences, economics and management, medicine, humanities, theology, fine art, music and drama. Their 47 700 students and 7 500 employees are based at their campuses in Lund, Malm and Helsingborg. The University has a turnover of around SEK 7 475 million (EUR 844 million), of which two thirds is in research and one third in education. They are an international university with global recruitment. They cooperate with 680 partner universities in over 50 countries and are the only Swedish university to be a member of the strong international networks LERU (the League of European Research Universities) and Universitas 21. Two major facilities for materials research are currently under construction in Lund: the MAX IV Laboratory, which will be a world-leading synchrotron radiation laboratory and ESS, a European facility that will be home to the world's most powerful neutron source. These will be of decisive importance for materials and life sciences and for industrial development. In Lund, Medicon Village has also been established and will offer a unique environment for life sciences; integrating research, innovation and enterprise creates the conditions for improved health and quality of life.

Executives & Employees

Founder

President & Director

Chief Financial Officer

Dean of the Faculty of Medicine

Head of Administration

Head, Department of Arts & Cultural Sciences

Head of Procurement

Head-Legal Division

Head-Department of Biotechnology

Director-Rausing Laboratory & Professor

Board of Directors

Chairman at Lund University

Chief Communications Officer at Qeep Group AB

Director at Skandinaviska Enskilda Banken AB

Former Senior Vice President, Chief Marketing & Communications Officer & Head of Group Function Marketing & Corporate Relations at Telefonaktiebolaget LM Ericsson

Director at Aptahem AB

Chief Executive Officer at AQILION AB

President & Director at Lund University

Distinguished Alumni
Mikael Dolsten is now Chief Scientific Officer & Research President at Pfizer, Inc.
David Scadden is now Co-Founder at Fate Therapeutics, Inc.
Jörn Rausing is now Head-Mergers & Acquisitions at Tetra Laval AB
Paths to Lund University
Potential Connections via
Relationship Science
You
Lund University
Clients

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector (LVV) and adeno-associated viral vector (AAV) gene therapy platforms. The firm's clinical program is a LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded on July 7, 1999 and is headquartered in New York, NY.

Avrobio, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen. The firm's clinical-stage programs include Fabry, Gaucher Type 1, Hunter syndrome Gaucher Type 3, Pompe, and Cystinosis. The company was founded by Geoff Mackay, Kim Warren, Christopher Mason, and Jeffrey Medin in 2015 and is headquartered in Cambridge, MA.

Non-Profit Donations & Grants Received
Investments
Details Hidden

SpectraCure AB engages in the research, development, and provision of equipment for cancer treatments. It focuses on cancer treatments using medical systems with laser light sources and reactive drugs, which are referred to as interstitial photodynamic therapy. The company was founded by Sune Roland Svanberg, Katarina Svanberg, and Stefan Andersson-Engels in March 2003 and is headquartered in Lund, Sweden.

Suppliers
AddLife AB Biotechnology | Stockholm, Sweden

AddLife AB engages in the ownership and acquisition of companies in niche segments under the healthcare sector. It operates through the Labtech and Medtech business areas. The Labtech business area provides a range of services in diagnostics, biomedical research, and laboratory analysis. The Medtech business area focuses on publicly funded health, homecare, and social services. The company was founded in 1906 and is headquartered in Stockholm, Sweden.

Assa Abloy AB Tools & Hardware | Stockholm, Sweden

ASSA ABLOY We open doors to events, museums, airports, hotels, homes… in fact, we open doors to life. As the global leader in door opening solutions we are dedicated to satisfying end-user needs for security, safety and convenience. ASSA ABLOY is represented on both mature and emerging markets worldwide, with leading positions in much of Europe, North America, Asia and the Pacific. Since its formation in 1994, ASSA ABLOY has grown from a regional company into an international group with around 43,000 employees, sales of about SEK 47 billion and own operations in over 70 countries. ASSA ABLOY offers a more complete range of door opening solutions than any other company on the market. In the fast-growing electromechanical security segment, the Group has a leading position in areas such as access control, identification technology, entrance automation and hotel security. The ASSA ABLOY Group’s overall strategy focus is to spearhead the trend towards higher security with a product-driven offering centered on the customer. Our vision is- to be the world-leading, most successful and most innovative provider of total door opening solutions; to lead in innovation and offer well-designed, convenient, safe and secure solutions that create added value for our customers and to offer an attractive company to our employees. With our historical timeline we take you from our formation in 1994 up until today. The locks and security solutions from ASSA ABLOY stand for high quality. Our product offer include mechanical locks – such as door locks and cylinder locks – and security doors; as well as mobile keys, electromechanical locks, electronic locks, door closers, door automatics, access control systems and identification, smart cards and RFID readers.

Quanterix Corp. Biotechnology | Lexington, MA

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Lund University. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Lund University's profile does not indicate a business or promotional relationship of any kind between RelSci and Lund University.